Compare ANIP & JJSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIP | JJSF |
|---|---|---|
| Founded | 2001 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.8B |
| IPO Year | N/A | N/A |
| Metric | ANIP | JJSF |
|---|---|---|
| Price | $82.18 | $94.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | $102.14 | ★ $138.33 |
| AVG Volume (30 Days) | ★ 395.1K | 310.8K |
| Earning Date | 11-07-2025 | 02-02-2026 |
| Dividend Yield | N/A | ★ 3.40% |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.67 | ★ 3.36 |
| Revenue | $826,880,000.00 | ★ $3,166,466,000.00 |
| Revenue This Year | $43.41 | N/A |
| Revenue Next Year | $9.66 | $2.24 |
| P/E Ratio | $48.42 | ★ $28.05 |
| Revenue Growth | ★ 48.87 | 0.54 |
| 52 Week Low | $52.50 | $80.67 |
| 52 Week High | $99.50 | $169.42 |
| Indicator | ANIP | JJSF |
|---|---|---|
| Relative Strength Index (RSI) | 44.40 | 60.47 |
| Support Level | $79.98 | $89.94 |
| Resistance Level | $83.00 | $94.05 |
| Average True Range (ATR) | 2.18 | 2.01 |
| MACD | 0.28 | 0.41 |
| Stochastic Oscillator | 43.09 | 77.57 |
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
J&J Snack Foods Corp. manufactures snack foods and distributes frozen beverages, which it markets nationally to the foodservice and retail supermarket industries. The company's portfolio of frozen beverages, frozen novelties, and baked goods includes soft pretzels, frozen juice treats and desserts, stuffed sandwiches, churros, funnel cakes, cookies, and other snack foods and drinks. It operates through three segments: Food Service, which sells snacks, desserts, and baked goods at the point of sale; Retail Supermarkets, which sells frozen and prepackaged products to supermarkets; and Frozen Beverages, which sells frozen beverages under the ICEE, Slush Puppie, and Parrot Ice brands in the United States, Mexico, and Canada. The majority of revenue comes from the Food Service segment.